Assessing the individual benefits of reducing HIV diagnosis delay and increasing adherence to HIV care and treatment

References

• AHEAD. (2022). America’s HIV epidemic analysis dashboard. https://ahead.hiv.gov/about-ehe. Accessed on December 2, 2022.
   Google Scholar
• Bagchi, A. D., & Davis, T. (2020). Clinician barriers and facilitators to routine HIV testing: A systematic review of the literature. Journal of the International Association of Providers of AIDS Care (JIAPAC), 19, 1–9. https://doi.org/10.1177/2325958220936014
   Google Scholar
• Bavinton, B. R., Pinto, A. N., Phanuphak, N., Grinsztejn, B., Prestage, G. P., Zablotska-Manos, I. B., Jin, F., Fairley, C. K., Moore, R., Roth, N., Bloch, M., Pell, C., McNulty, A. M., Baker, D., Hoy, J., Tee, B. K., Templeton, D. J., Cooper, D. A., Emery, S., Kelleher, A., Grulich, A. E., & Opposites Attract Study, G. (2018). Viral suppression and HIV transmission in serodiscordant Male couples: An international, prospective, observational, cohort study. The Lancet HIV, 5(8), e438–e447. https://doi.org/10.1016/S2352-3018(18)30132-2
   PubMed Web of Science ®Google Scholar
• Bingham, A., Shrestha, R. K., Khurana, N., Jacobson, E. U., & Farnham, P. G. (2021). Estimated lifetime HIV-related medical costs in the United States. Sexually Transmitted Diseases, 48(4), 299–304. https://doi.org/10.1097/OLQ.0000000000001366
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2018a). Estimated HIV incidence and prevalence in the United States, 2010–2015. HIV Surveillance Supplemental Report, 23(1), 1–77. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published March 2018.
   Google Scholar
• Centers for Disease Control and Prevention. (2018b). Monitoring selected national HIV prevention and care objectives by using HIV Surveillance Data—United States and 6 Dependent Areas, 2016. HIV Surveillance Supplemental Report, 23(4), 1–51. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published June 2018.
   Google Scholar
• Centers for Disease Control and Prevention. (2021). Estimated HIV incidence and prevalence in the United States, 2015–2019. HIV Surveillance Supplemental Report, 26(1), 1–81. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published May 2021.
   Google Scholar
• Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H., Godbole, S. V., Chariyalertsak, S., Santos, B. R., Mayer, K. H., Hoffman, I. F., Eshleman, S. H., Piwowar-Manning, E., Cottle, L., Zhang, X. C., … Team, H. S. (2016). Antiretroviral therapy for the prevention of HIV-1 transmission. New England Journal of Medicine, 375(9), 830–839. https://doi.org/10.1056/NEJMoa1600693
   PubMed Web of Science ®Google Scholar
• Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H., Godbole, S. V., Mehendale, S., Chariyalertsak, S., Santos, B. R., Mayer, K. H., Hoffman, I. F., Eshleman, S. H., Piwowar-Manning, E., Wang, L., … Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365(6), 493–505. https://doi.org/10.1056/NEJMoa1105243
   PubMed Web of Science ®Google Scholar
• Crepaz, N., Song, R., Lyss, S. B., & Hall, H. I. (2021). Estimated time from HIV infection to diagnosis and diagnosis to first viral suppression during 2014 to 2018. Aids (london, England), 35(13), 2181–2190. https://doi.org/10.1097/QAD.0000000000003008.
   PubMed Web of Science ®Google Scholar
• Dailey, A. F., Hoots, B. E., Hall, H. I., Song, R., Hayes, D., Fulton, P., Jr., Prejean, J., Hernandez, A. L., Koenig, L. J., & Valleroy, L. A. (2017). Vital signs: Human immunodeficiency virus testing and diagnosis delays — United States. MMWR. Morbidity and Mortality Weekly Report, 66(47), 1300-1306. https://doi.org/10.15585/mmwr.mm6647e1
   PubMed Web of Science ®Google Scholar
• Farnham, P. G., Gopalappa, C., Sansom, S. L., Hutchinson, A. B., Brooks, J. T., Weidle, P. J., Marconi, V. C., & Rimland, D. (2013). Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: Late versus early diagnosis and entry into care. JAIDS Journal of Acquired Immune Deficiency Syndromes, 64(2), 183–189. https://doi.org/10.1097/QAI.0b013e3182973966
   PubMed Web of Science ®Google Scholar
• Farnham, P. G., Holtgrave, D. R., Gopalappa, C., Hutchinson, A. B., & Sansom, S. L. (2013). Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era. JAIDS Journal of Acquired Immune Deficiency Syndromes, 64(2), e15–e18. https://doi.org/10.1097/QAI.0b013e3182a5c8d4
   PubMed Web of Science ®Google Scholar
• Fauci, A. S., Redfield, R. R., Sigounas, G., Weahkee, M. D., & Giroir, B. P. (2019). Ending the HIV epidemic: A plan for the United States. JAMA, 321(9), 844–845. https://doi.org/10.1001/jama.2019.1343
   PubMed Web of Science ®Google Scholar
• Hutchinson, A. B., Farnham, P. G., Sansom, S. L., Yaylali, E., & Mermin, J. H. (2016). Cost-effectiveness of frequent HIV testing of high-risk populations in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes, 71(3), 323–330. https://doi.org/10.1097/QAI.0000000000000838
   PubMed Web of Science ®Google Scholar
• Hutchinson, A. B., Hicks, K. A., Yaylali, E., & Mermin, J. H. (2017, February 13–16). Cost-Effectiveness of HIV screening of heterosexuals in the United States. Poster presented at: Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, Washington.
   Google Scholar
• Lennox, J. L., Dejesus, E., Berger, D. S., Lazzarin, A., Pollard, R. B., Ramalho Madruga, J. V., Zhao, J., Wan, H., Gilbert, C. L., Teppler, H., Rodgers, A. J., Barnard, R. J., Miller, M. D., Dinubile, M. J., Nguyen, B. Y., Leavitt, R., & Sklar, P. (2010). Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses. JAIDS Journal of Acquired Immune Deficiency Syndromes, 55(1), 39–48. https://doi.org/10.1097/QAI.0b013e3181da1287
   PubMed Web of Science ®Google Scholar
• Lennox, J. L., DeJesus, E., Lazzarin, A., Pollard, R. B., Madruga, J. V., Berger, D. S., Zhao, J., Xu, X., Williams-Diaz, A., Rodgers, A. J., Barnard, R. J., Miller, M. D., DiNubile, M. J., Nguyen, B. Y., Leavitt, R., Sklar, P., & investigators, S. (2009). Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: A multicentre, double-blind randomised controlled trial. The Lancet, 374(9692), 796–806. https://doi.org/10.1016/S0140-6736(09)60918-1
   PubMed Web of Science ®Google Scholar
• Li, Z., Purcell, D. W., Sansom, S. L., Hayes, D., & Hall, H. I. (2019). Vital signs: HIV transmission along the continuum of care — United States, 2016. MMWR. Morbidity and Mortality Weekly Report, 68(68), 267–272. https://doi.org/10.15585/mmwr.mm6811e1
   PubMedGoogle Scholar
• Malekinejad, M., Blodgett, J., Horvath, H., Parriott, A., Hutchinson, A. B., Shrestha, R. K., McCabe, D., Volberding, P., & Kahn, J. G. (2021). Change in condom use in populations newly aware of HIV diagnosis in the United States and Canada: A systematic review and meta-analysis. AIDS and Behavior, 25(6), 1839–1855. https://doi.org/10.1007/s10461-020-03113-8
   PubMed Web of Science ®Google Scholar
• McFarland, W., Chen, Y. H., Nguyen, B., Grasso, M., Levine, D., Stall, R., Colfax, G., Robertson, T., Truong, H. M., & Raymond, H. F. (2012). Behavior, intention or chance? A longitudinal study of HIV seroadaptive behaviors, abstinence and condom use. AIDS and Behavior, 16(1), 121–131. https://doi.org/10.1007/s10461-011-9936-8
   PubMed Web of Science ®Google Scholar
• Paz-Bailey, G., Mendoza, M. C., Finlayson, T., Wejnert, C., Le, B., Rose, C., Raymond, H. F., Prejean, J., & Group, N. S. (2016). Trends in condom use among MSM in the United States: The role of antiretroviral therapy and seroadaptive strategies. Aids (london, England), 30(12), 1985–1990. https://doi.org/10.1097/QAD.0000000000001139
   PubMed Web of Science ®Google Scholar
• Rodger, A. J., Cambiano, V., Bruun, T., & Partner study group. (2018, July 23). Risk of HIV transmission through condomless sex in MSM couples with suppressive ART: the PARTNER2 Study extended results in gay men. AIDS 2018: 22nd International AIDS Conference, Amsterdam, Netherlands.
   Google Scholar
• Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., van Lunzen, J., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., Asboe, D., Viciana, P., Gutierrez, F., Clotet, B., Pradier, C., Gerstoft, J., Weber, R., Westling, K., Wandeler, G., … Group, P. S. (2016). Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA, 316(2), 171–181. https://doi.org/10.1001/jama.2016.5148
   PubMed Web of Science ®Google Scholar
• Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., Buchacz, K., Burchell, A. N., Cohen, M., Gebo, K. A., Gill, M. J., Justice, A., Kirk, G., Klein, M. B., Korthuis, P. T., Martin, J., Napravnik, S., Rourke, S. B., Sterling, T. R., Silverberg, M. J., … Gange, S. J. (2013). Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One, 8(12), e81355. https://doi.org/10.1371/journal.pone.0081355
   PubMed Web of Science ®Google Scholar
• Trickey, A., May, M. T., Vehreschild, J.-J., Obel, N., Gill, M. J., Crane, H. M., Boesecke, C., Patterson, S., Grabar, S., Cazanave, C., Cavassini, M., Shepherd, L., Monforte, A. d. A., van Sighem, A., Saag, M., Lampe, F., Hernando, V., Montero, M., Zangerle, R., … Sterne, J. A. C. (2017). Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies. The Lancet HIV, 4(8), e349–e356. https://doi.org/10.1016/S2352-3018(17)30066-8
   PubMed Web of Science ®Google Scholar
• Uzun Jacobson, E., Hicks, K. A., Carrico, J., Purcell, D. W., Green, T. A., Mermin, J. H., & Farnham, P. G. (2022). Optimizing HIV prevention efforts to achieve EHE incidence targets. JAIDS Journal of Acquired Immune Deficiency Syndromes, 89(4), 374–380. https://doi.org/10.1097/QAI.0000000000002885
   PubMed Web of Science ®Google Scholar
• Uzun Jacobson, E., Hicks, K. A., Tucker, E. L., Farnham, P. G., & Sansom, S. L. (2018). Effects of reaching national goals on HIV incidence, by race and ethnicity, in the United States. Journal of Public Health Management and Practice, 24(4), E1–E8. https://doi.org/10.1097/PHH.0000000000000717
   PubMed Web of Science ®Google Scholar
• Wilensky, U. (1999). Center for connected learning and computer-based modeling, Northwestern University. Evanston, IL. Netlogo. http://ccl.northwestern.edu/netlogo/
   Google Scholar